Cite
Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers.
MLA
Wang, Dongmo, et al. “Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers.” Ultrasound in Medicine & Biology, vol. 44, no. 5, May 2018, pp. 1124–32. EBSCOhost, https://doi.org/10.1016/j.ultrasmedbio.2018.01.013.
APA
Wang, D., Zhu, K., Tian, J., Li, Z., Du, G., Guo, Q., Wu, T., & Li, J. (2018). Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers. Ultrasound in Medicine & Biology, 44(5), 1124–1132. https://doi.org/10.1016/j.ultrasmedbio.2018.01.013
Chicago
Wang, Dongmo, Kai Zhu, Jiawei Tian, Ziyao Li, Guoqing Du, Qiang Guo, Tong Wu, and Juan Li. 2018. “Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers.” Ultrasound in Medicine & Biology 44 (5): 1124–32. doi:10.1016/j.ultrasmedbio.2018.01.013.